BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1370640)

  • 1. Myeloid and erythroid progenitor cells from normal bone marrow adhere to collagen type I.
    Koenigsmann M; Griffin JD; DiCarlo J; Cannistra SA
    Blood; 1992 Feb; 79(3):657-65. PubMed ID: 1370640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin increases both non-adherent cells and CFU-GM while collagen increases adherent cells in human normal long-term bone marrow cultures.
    Hassan HT; Sadovinkova EYu ; Drize NJ; Zander AR; Neth R
    Haematologia (Budap); 1997; 28(2):77-84. PubMed ID: 9283907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts.
    Coulombel L; Vuillet MH; Leroy C; Tchernia G
    Blood; 1988 Feb; 71(2):329-34. PubMed ID: 3337901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
    Verfaillie CM; McCarthy JB; McGlave PB
    J Clin Invest; 1992 Oct; 90(4):1232-41. PubMed ID: 1383271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines.
    Bruno E; Luikart SD; Long MW; Hoffman R
    Exp Hematol; 1995 Oct; 23(11):1212-7. PubMed ID: 7556532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesive interactions of human multiple myeloma cell lines with different extracellular matrix molecules.
    Kibler C; Schermutzki F; Waller HD; Timpl R; Müller CA; Klein G
    Cell Adhes Commun; 1998 Jun; 5(4):307-23. PubMed ID: 9762471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific domains of fibronectin mediate adhesion and migration of early murine erythroid progenitors.
    Goltry KL; Patel VP
    Blood; 1997 Jul; 90(1):138-47. PubMed ID: 9207447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of heterotypic adherence between transformed human lymphoblastic cells and marrow stromal cells: VCAM-1 is a ligand for one of the leukemia cell adhesion proteins.
    Juneja HS; Rajaraman S; Gay RE; Gay S; Schmalsteig FC
    Exp Hematol; 1992 Dec; 20(11):1263-70. PubMed ID: 1283595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation.
    Vellenga E; Sizoo W; Hagenbeek A; Löwenberg B
    Br J Haematol; 1987 Feb; 65(2):137-42. PubMed ID: 3548797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
    Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
    Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.
    Verfaillie C; McGlave P
    Blood; 1991 Jan; 77(2):263-70. PubMed ID: 1702332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo.
    Ottmann OG; Ganser A; Seipelt G; Eder M; Schulz G; Hoelzer D
    Blood; 1990 Oct; 76(8):1494-502. PubMed ID: 2207325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of hematopoietic stem cell development: reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitors.
    Brashem-Stein C; Flowers DA; Smith FO; Staats SJ; Andrews RG; Bernstein ID
    Blood; 1993 Aug; 82(3):792-9. PubMed ID: 8338945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
    Broxmeyer HE; Lu L; Hangoc G; Cooper S; Hendrie PC; Ledbetter JA; Xiao M; Williams DE; Shen FW
    J Exp Med; 1991 Aug; 174(2):447-58. PubMed ID: 1713254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.